Tal Wilk-Glazer will also join Sativus Tech Corp's Board of Directors assuming the Director role. Moshe Bar Siman Tov recently announced his departure after being named as Head of the Health Insurance division of Clal Insurance. Bar Siman Tov led Sativus Tech's strategy discussions and took an intricate role in forming the company's positioning in the pharmaceutical and food supplement sectors.

Iris Ginsburg also departs the board to pursue another role. Tal Wilk-Glazer became CEO of Sativus Tech's subsidiary, Saffron Tech, in December 2021. In that short amount of time, she successfully established the company's first operating R&D facility in southern Israel.

She also entered a joint venture with Naveh Pharma to develop and distribute saffron-based food supplements and beauty products.